Reader-supported. We may earn a commission when you use our partner links. How we’re funded
Our take
MadeMed is worth comparing if format choice matters. I would choose the formulation with the clinician first, then request the complete price and fulfillment terms.
What stands out
- Separate injection and oral listings
- Both starting prices published
- Doctor-prescribed delivery model described
What to weigh
- Starting rates do not establish final totals
- Oral and injected treatment are not interchangeable
- Product-specific terms need confirmation
Two products deserve two comparisons
MadeMed's treatment catalog lists injectable sermorelin from $169 per month and an oral troche from $99 per month. The separate listings are useful: a reader can see that the needle-free option is a different purchase rather than discovering that distinction after starting an intake. Source: MadeMed's official treatment catalog.
I would still avoid letting the cheaper number decide the format. The clinical question comes first: why is this particular formulation being proposed for your concern? Only after that discussion does it make sense to compare prices with providers offering a comparable product. A convenient route of administration is a preference worth discussing, but it is not a substitute for evidence about that route.
Do not let a starting price become a full quote
The word “from” leaves room for a different final price. Before choosing either MadeMed product, ask what quantity the advertised amount purchases, how long that supply is expected to last and whether there are minimum purchase terms. Confirm whether the initial consultation, subsequent clinical contact, shipping and supplies belong in that total.
I would request the ongoing price as well as the amount due today. A price comparison is incomplete if one provider's figure covers the first shipment and another's covers recurring care. Our quote comparison guide provides a useful structure. It also helps separate a monthly equivalent on a longer purchase from an actual month-to-month commitment.
An oral option changes the questions
For someone who strongly prefers to avoid injections, the oral listing may be MadeMed's main attraction. That is a legitimate convenience preference. The important follow-up is whether the clinician can discuss the specific troche, the evidence relevant to it and the uncertainty that remains, without simply borrowing claims from injection research.
Our sermorelin lozenge evidence review explains why an absorption story alone does not answer every outcome question. Ask what would count as a meaningful response in your case and what would lead to reassessment. If an explanation treats all delivery formats as automatically interchangeable, I would ask for the reasoning before paying for a longer course.
Use the larger catalog carefully
MadeMed presents sermorelin within a broader prescription treatment catalog. A single platform can be convenient when someone already receives another service there, but convenience should not quietly become a reason to add a medication. Bring your complete current treatment list to the consultation, including products prescribed elsewhere.
I would want a clear explanation of whether the proposed plan addresses an unmet concern and how the care team will coordinate with existing clinicians. If more than one new treatment is proposed, ask how changes will be assessed and who is responsible for follow-up. This is especially relevant when several products are marketed toward overlapping goals such as energy, recovery or body composition. More purchases do not automatically create a more informative care plan.
Get a product-specific fulfillment answer
The catalog confirms an offering; it does not, by itself, identify every detail of a future prescription. Ask MadeMed to name the dispensing pharmacy and explain the actual formulation and supply. For an injection, establish what preparation assistance and supplies come with the order. For a troche, request the pharmacy's own handling instructions and the exact ingredients rather than relying on a general category description.
Also ask how an order can be stopped before fulfillment and what happens to prepaid funds if care changes. A responsive answer should distinguish canceling a future renewal from reversing an order already prepared. Those practical details are particularly important when the website makes it easy to move directly from a product category into an intake.
My assessment of MadeMed
MadeMed earns a place in a format-focused comparison because it labels the two options and their starting prices separately. I would not call it the better value until a written quote identifies the selected product and complete payment schedule. The least expensive option on a menu can still be the wrong purchase for the question you are trying to answer.
This review reflects public pages checked in October 2026. It is not a treatment testimonial, a pharmacy inspection or a finding that the advertised benefits will occur. A good next step is to compare the proposed formulation with our guide to reading evidence claims and bring any remaining questions to the prescribing clinician.
Common questions
What starting prices does MadeMed publish?
Its treatment catalog lists injectable sermorelin from $169 monthly and oral sermorelin from $99 monthly. These are starting figures, not confirmed personalized quotes.
Does MadeMed offer an oral option?
Yes. The catalog identifies an oral troche as a separate offering.
Are the two formats equivalent?
This review does not establish equivalence. Ask for evidence and a clinical explanation specific to the prescribed formulation.
Explore MadeMed
See the current offer and decide whether you want to start a consultation.
Visit MadeMedReader-supported. We may earn a commission when you use our partner links. How we’re funded
Sources & further reading
Sources reviewed October 2026. Provider prices and terms may change.